Everything You Need to Know About Posterior pituitary hormones for Step 1

Posterior pituitary hormones are some of the most testable “small but deadly” endocrine facts on Step 1: just two hormones (ADH and oxytocin), but they connect neuroanatomy, renal physiology, obstetrics, pharmacology, and a handful of classic pathology vignettes. If you can quickly map where they’re made, how they’re released, what receptors they hit, and what happens when they’re too low or too high, you’ll pick up a lot of easy points.

---

Posterior Pituitary (Neurohypophysis): The Big Picture

What it is (definition)

The posterior pituitary is neural tissue that stores and releases hormones made in the hypothalamus. It does not synthesize its own hormones.

High-yield anatomy/function

• Synthesized in hypothalamus:
  • ADH (vasopressin): primarily supraoptic nucleus
  • Oxytocin: primarily paraventricular nucleus
• Transported down axons via the hypothalamo-hypophyseal tract
• Stored in axon terminals and released into blood from posterior pituitary
• Histology clue: Herring bodies = neurosecretory granules in posterior pituitary

💡

First Aid cross-reference: Endocrine → Hypothalamus & Pituitary (posterior pituitary; ADH/oxytocin), and Renal → ADH physiology; Repro → lactation/uterine contraction.

---

Posterior Pituitary Hormones at a Glance (Table)

---

ADH (Vasopressin): Physiology That Shows Up Everywhere

Receptors and signaling (very testable)

• V2 receptors (kidney collecting duct principal cells): Gs → ↑ cAMP
  • Inserts aquaporin-2 into apical membrane → ↑ free water reabsorption
• V1 receptors (vascular smooth muscle): Gq → ↑ IP3/DAG → ↑ Ca²⁺
  • Vasoconstriction (helps maintain perfusion in shock)

Renal physiology pearl

• ADH primarily regulates free water, not sodium directly.
• Effect on labs: ADH tends to lower serum osmolality and concentrate urine.

Regulation (how boards phrase it)

ADH release increases with:

• ↑ plasma osmolality (osmoreceptors in hypothalamus)
• ↓ effective arterial blood volume / BP (baroreceptors)
• Nausea (potent stimulus), pain, stress

ADH release decreases with:

• Ethanol (classic “beer diuresis” vignette)
• Water loading, low osmolality

---

Disorders of ADH

1) Diabetes Insipidus (DI)

Definition

Failure to concentrate urine due to low ADH (central DI) or renal resistance to ADH (nephrogenic DI).

Pathophysiology and causes

Central DI (↓ ADH production/release)

• Idiopathic, autoimmune
• Neurosurgery, head trauma
• Tumors affecting hypothalamus/posterior pituitary (e.g., craniopharyngioma regionally—more classically anterior pituitary dysfunction, but can affect stalk/posterior function)
• Infiltrative disease (sarcoidosis, Langerhans cell histiocytosis)

Nephrogenic DI (ADH present but kidney unresponsive)

• Lithium toxicity (most classic USMLE association)
• Demeclocycline
• Hypercalcemia, hypokalemia
• Congenital mutations (V2 receptor, AQP2)

💡

First Aid cross-reference: Pharmacology (lithium; demeclocycline), Renal (collecting duct physiology), Endocrine (DI).

Clinical presentation

• Polyuria (often >3 L/day), polydipsia
• Nocturia
• Signs of dehydration if water access limited
• Labs (typical):
  • ↑ serum osmolality
  • ↑ serum sodium (if water intake doesn’t keep up)
  • Low urine osmolality (dilute urine)

Diagnosis (high-yield testing algorithm)

Water deprivation test + desmopressin (DDAVP) challenge:

Tip: If the stem mentions psychiatric history + compulsive water drinking → think primary polydipsia.

Treatment

• Central DI: Desmopressin (DDAVP)
  • Selective V2 agonist → fewer V1 vasoconstrictive effects
• Nephrogenic DI:
  • Stop offending drug (e.g., lithium) if possible
  • Thiazides (paradoxical ↓ polyuria via mild volume depletion → ↑ proximal reabsorption)
  • Amiloride for lithium-induced DI (blocks lithium entry via ENaC)
  • NSAIDs can reduce urine output (↓ prostaglandins that antagonize ADH)

Classic adverse effect to know

• Over-treatment with desmopressin → hyponatremia.

---

2) SIADH (Syndrome of Inappropriate ADH)

Definition

Excess ADH → water retention → euvolemic hyponatremia with inappropriately concentrated urine.

Pathophysiology (Step framing)

• Too much ADH → too much free water reabsorbed → dilutional hyponatremia
• Body responds by:
  • ↓ aldosterone and ↑ ANP → natriuresis (helps maintain euvolemia)
• Net result: not typically edema-heavy like CHF; classically euvolemic

Causes (must-know list)

• Small cell carcinoma of the lung (ectopic ADH production)
• CNS disturbance: stroke, hemorrhage, infection, trauma
• Pulmonary disease: pneumonia, TB
• Drugs: SSRIs, carbamazepine, cyclophosphamide, chlorpropamide, MDMA

💡

First Aid cross-reference: Pulmonary/Onc (small cell lung carcinoma), Pharm (SSRIs, carbamazepine), Endocrine (SIADH), Renal (free water handling).

Clinical presentation

Symptoms are driven by hyponatremia:

• Mild/moderate: nausea, headache, confusion
• Severe/acute: seizures, coma

Diagnostic pattern (high yield)

Typical labs:

• ↓ serum Na⁺
• ↓ serum osmolality
• Inappropriately ↑ urine osmolality
• ↑ urine sodium (often due to natriuresis)

Differentials to distinguish

• CHF/cirrhosis/nephrotic syndrome: hyponatremia but typically hypervolemic with edema, low effective arterial volume.
• Adrenal insufficiency can also cause hyponatremia—look for hypotension, hyperkalemia, low cortisol.

Treatment

Depends on severity and acuity:

• Fluid restriction (foundation)
• Oral salt/IV saline depending on scenario
• Hypertonic (3%) saline for severe symptoms (e.g., seizures)
• Demeclocycline (induces nephrogenic DI) for chronic SIADH (less used clinically now but still board-relevant)
• Vaptans (ADH receptor antagonists): conivaptan, tolvaptan

Critical safety point: correcting sodium Avoid osmotic demyelination syndrome (central pontine myelinolysis) from overly rapid correction. A commonly tested rule: do not increase Na⁺ by more than about 8–10 mEq/L in 24 hours in most cases (institutions vary slightly).

---

Oxytocin: The “Positive Feedback” Posterior Pituitary Hormone

Core physiology

Oxytocin is released in response to:

• Nipple stimulation → milk ejection (“let-down” reflex)
• Cervical/uterine stretch → stronger uterine contractions

It works via Gq signaling, increasing intracellular calcium → smooth muscle contraction.

High-yield distinction: prolactin vs oxytocin

💡

Boards love to ask: postpartum patient can produce milk but can’t eject → think oxytocin problem (often stress/pain inhibiting let-down).

Clinical use (pharm tie-in)

• Oxytocin can be used for:
  • Induction/augmentation of labor
  • Treatment of postpartum hemorrhage due to uterine atony (contracts uterus)

Adverse effects to recognize

• Uterine hyperstimulation → fetal distress
• Water intoxication/hyponatremia can occur rarely (oxytocin has mild ADH-like activity at high doses)

💡

First Aid cross-reference: Repro/OB pharm (oxytocin; uterine atony), Endocrine (posterior pituitary).

---

Integrating Posterior Pituitary with Hypothalamic-Pituitary Concepts

Posterior pituitary is “just release”

A classic trap is mixing up anterior vs posterior:

• Anterior pituitary: glandular tissue; regulated by hypothalamic releasing hormones through portal circulation
• Posterior pituitary: neuronal axons; hormones synthesized in hypothalamus, transported down axons, stored/released

Lesions and clinical reasoning

• Pituitary adenomas classically affect the anterior pituitary (prolactin, GH, ACTH, etc.)
• Posterior pituitary dysfunction more often comes from:
  • Trauma/surgery
  • Stalk damage
  • Infiltrative disease
  • Ectopic hormone production (SIADH from small cell lung cancer)

---

Rapid-Fire High-Yield Associations (Exam-Day Bullets)

ADH

• Ethanol inhibits ADH → diuresis
• V2 = 2 kidneys (Gs) → aquaporin-2 insertion
• Lithium → nephrogenic DI
• Desmopressin treats central DI (and some bleeding disorders like vWD; know this as a bonus cross-link)
• SIADH:
  • Small cell lung carcinoma
  • Euvolemic hyponatremia
  • Treat with fluid restriction, vaptans, sometimes demeclocycline
• Overcorrect hyponatremia → osmotic demyelination

Oxytocin

• Milk ejection, not production
• Uterine contraction; used for induction and postpartum hemorrhage
• Positive feedback loops (suckling/stretch → more oxytocin)

---

Mini Practice Vignettes (How It’s Tested)

1. Psych patient drinking water all day, low-normal sodium, urine becomes concentrated after water deprivation
   → Primary polydipsia

2. Post-op neurosurgery patient with polyuria, high serum osmolality, urine remains dilute but concentrates after DDAVP
   → Central DI

3. Patient on lithium with polyuria; DDAVP does not improve urine concentration
   → Nephrogenic DI

4. Smoker with lung mass, confusion, Na⁺ 118, low serum osmolality, high urine osmolality
   → SIADH from small cell carcinoma

5. Postpartum patient: milk present but “won’t let down,” stressed and in pain
   → impaired oxytocin-mediated ejection (supportive measures; reduce stress/pain)

---

Key Takeaway Map (One-Liner Memory Hooks)

• Posterior pituitary stores/releases; hypothalamus makes.
• ADH: V2 (Gs) collecting duct water; too little = DI, too much = SIADH.
• Oxytocin: let-down + labor via Gq; think postpartum hemorrhage treatment.